Levo-tetrahydropalmatine attenuates mouse blood-brain barrier injury induced by focal cerebral ischemia and reperfusion: Involvement of Src kinase

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mao, Xiao Wei ^a,b   Pan, Chun Shui ^a,b   Huang, Ping ^a,b   Liu, Yu Ying ^a,b   Wang, Chuan She ^a,b   Yan, Li ^a,b   Hu, Bai He ^a,b   Chang, Xin ^a,b   He, Ke ^a,b   Mu, Huan Na ^a,b   Li, Quan ^a,b   Sun, Kai ^a,b   Fan, Jing Yu ^a,b   Han, Jing Yan ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b State Administration of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE DERIVATIVE; PROTEIN TYROSINE KINASE; TETRAHYDROPALMATINE;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; C57BL MOUSE; DRUG EFFECTS; ENZYMOLOGY; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; BERBERINE ALKALOIDS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; SRC-FAMILY KINASES;

EID: 84931275333     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11155     Document Type: Article

References (34)

1. Jung, J. E. et al. Reperfusion and neurovascular dysfunction in stroke: From basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 41, 172-179, doi:10.1007/s12035-010-8102-z (2010).
2. Hacke, W. et al. Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience. Neurology 53, S3-14 (1999).
3. Abbott, N. J., Ronnback, L. & Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7, 41-53, doi:10.1038/nrn1824 (2006).
4. Schubert, W. et al. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem 276, 48619-48622, doi:10.1074/jbc.C100613200 (2001).
5. Ghitescu, L., Fixman, A., Simionescu, M. & Simionescu, N. Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: Receptor-mediated transcytosis. J Cell Biol 102, 1304-1311 (1986).
6. Sandoval, K. E. & Witt, K. A. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32, 200-219, doi:10.1016/j.nbd.2008.08.005 (2008).
7. Yu, H., Wang, P., An, P. & Xue, Y. Recombinant human angiopoietin-1 ameliorates the expressions of ZO-1, occludin, VEcadherin, and PKCalpha signaling after focal cerebral ischemia/reperfusion in rats. J Mol Neurosci 46, 236-247, doi:10.1007/s12031-011-9584-5 (2012).
8. Liu, J., Jin, X., Liu, K. J. & Liu, W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci 32, 3044-3057, doi:10.1523/JNEUROSCI.6409-11.2012 (2012).
9. Birukov, K. G. et al. Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src) J Biol Chem 276, 8567-8573, doi:10.1074/jbc.M005270200 (2001).
10. Kuhlmann, C. R. et al. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 102, 501-507, doi:10.1111/j.1471-4159.2007.04506.x (2007).
11. Shen, L. et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119, 2095-2106, doi:10.1242/jcs.02915 (2006).
12. Hu, G. & Minshall, R. D. Regulation of transendothelial permeability by Src kinase. Microvasc Res 77, 21-25, doi:10.1016/j. mvr.2008.10.002 (2009).
13. Baeten, K. M. & Akassoglou, K. Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev Neurobiol 71, 1018-1039, doi:10.1002/dneu.20954 (2011).
14. Candelario-Jalil, E., Yang, Y. & Rosenberg, G. A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158, 983-994, doi:10.1016/j.neuroscience .2008.06.025 (2009).
15. Kwon, I., Kim, E. H., del Zoppo, G. J. & Heo, J. H. Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia. J Neurosci Res 87, 668-676, doi:10.1002/jnr.21877 (2009).
16. Yang, Y. et al. Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery. J Cereb Blood Flow Metab 33, 1104-1114, doi:10.1038/jcbfm.2013.56 (2013).
17. Jin, R., Yang, G. & Li, G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: Critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 38, 376-385, doi:10.1016/j.nbd.2010.03.008 (2010).
18. Yang, G., Wang, P., Tang, Y., Jiang, C. & Wang, D. Effects of L-tetrahydropalmatine on energy metabolism, endothelin-1 and NO during acute cerebral ischemia-reperfusion of rats. J Tongji Med Univ 19, 285-287 (1999).
19. Yang, G., Jiang, C., Tang, Y. & Wang, P. Effects of L-tetrahydropalmatine on neuron apoptosis during acute cerebral ischemiareperfusion of rats. J Tongji Med Univ 20, 106-108 (2000).
20. Liu, B. & Yang, G. Effects of L-tetrahydropalmatine on the expressions of bcl-2 and bax in rat after acute global cerebral ischemia and reperfusion. J Huazhong Univ Sci Technolog Med Sci 24, 445-448 (2004).
21. Wang, J. B. & Mantsch, J. R. l-tetrahydropalamatine: A potential new medication for the treatment of cocaine addiction. Future Med Chem 4, 177-186, doi:10.4155/fmc.11.166 (2012).
22. Chu, H., Jin, G., Friedman, E. & Zhen, X. Recent development in studies of tetrahydroprotoberberines: Mechanism in antinociception and drug addiction. Cell Mol Neurobiol 28, 491-499, doi:10.1007/s10571-007-9179-4 (2008).
23. Han, Y. et al. l-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemia-reperfusion injury in rats. PLoS One 7, e38627, doi:10.1371/journal.pone.0038627 (2012).
24. Molina, C. A. & Alvarez-Sabin, J. Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis 27 Suppl 1, 162-167, doi:10.1159/000200455 (2009).
25. Guerrero, J., Santibanez, J. F., Gonzalez, A. & Martinez, J. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp Cell Res 292, 201-208 (2004).
26. Kale, G., Naren, A. P., Sheth, P. & Rao, R. K. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem Biophys Res Commun 302, 324-329 (2003).
27. Labrecque, L. et al. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem 279, 52132-52140, doi:10.1074/jbc.M409617200 (2004).
28. Barreto, G. E., White, R. E., Xu, L., Palm, C. J. & Giffard, R. G. Effects of heat shock protein 72 (Hsp72) on evolution of astrocyte activation following stroke in the mouse. Exp Neurol 238, 284-296, doi:10.1016/j.expneurol.2012.08.015 (2012).
29. Huang, P. et al. Cerebralcare Granule(R) attenuates blood-brain barrier disruption after middle cerebral artery occlusion in rats. Exp Neurol 237, 453-463, doi:10.1016/j.expneurol.2012.07.017 (2012).
30. Swanson, R. A. et al. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10, 290-293, doi:10.1038/jcbfm.1990.47 (1990).
31. Lu, C. et al. TLR2 ligand induces protection against cerebral ischemia/reperfusion injury via activation of phosphoinositide 3-kinase/Akt signaling. J Immunol 187, 1458-1466, doi:10.4049/jimmunol.1003428 (2011).
32. Xu, X. S. et al. The antioxidant Cerebralcare Granule attenuates cerebral microcirculatory disturbance during ischemiareperfusion injury. Shock 32, 201-209, doi:10.1097/SHK.0b013e3181996d61 (2009).
33. Fujimoto, M. et al. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab 28, 1674-1685, doi:10.1038/jcbfm.2008.59 (2008).
34. Zhao, H. P. et al. Caffeic acid inhibits acute hyperhomocysteinemia-induced leukocyte rolling and adhesion in mouse cerebral venules. Microcirculation 19, 233-244, doi:10.1111/j.1549-8719.2011.00151.x (2012).